Tech Company Financing Transactions
Centice Funding Round
Centice secured a $6.1 million Series C funding round on 10/22/2009. Investors included Aurora Funds, Fulcrum Financial Group and Innovation Ventures.
Transaction Overview
Company Name
Announced On
10/22/2009
Transaction Type
Venture Equity
Amount
$6,100,000
Round
Series C
Investors
Proceeds Purpose
The funds will be used to support ongoing commercialization efforts for Centice�s innovative PASS Rx prescription verification product for the retail and hospital outpatient pharmacy marketplace. Along with Fulcrum Financial Group, L.P., existing investors participating in the $6.1 million financing include The Aurora Funds, Inc., S-Group Direct Investments Ltd., Innovation Ventures LP and several individuals.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
215 Southport Dr. 1000
Morrisville, NC 27560
USA
Morrisville, NC 27560
USA
Phone
Website
Email Address
Overview
Centice Corporation is a leader in delivering unique technology and systems for identification and verification of chemical substances.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Goehrke
VP - Engineering
David Blaker
VP - Finance
Rob McLaughlin
Browse more venture capital transactions:
Prev: 10/22/2009: XOJET venture capital transaction
Next: 10/22/2009: Nuclea Biotechnologies venture capital transaction
Share this article
News on VC Transactions
We do our best to document funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs